Centogene's Biodatabank Drives Rare Disease Breakthroughs
Centogene N.V. Explores Financial Strategies
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Shares of Wang & Lee Group, Inc. (NASDAQ:WLGS) rose sharply in today's pre-market trading after the company reported a year-over-year increase in FY23 financial results.Wang & Lee Group posted a FY23
Centogene N.V. Faces Nasdaq Compliance Challenge
Centogene Receives Non-Compliance Notification Letter Dated March 27, 2024, From Nasdaq
In accordance with Listing Rule 5810(c)(3)(A) of the Nasdaq Listing Rules, the Company has a period of 180 calendar days from the date of notification to regain compliance with the minimum bid price r
CENTOGENE Receives Nasdaq Non-Compliance Notice
Centogene N.V. (NASDAQ:CNTG) ("Centogene", "we", or the "Company"), the essential life science partner for data-driven answers in rare and neurodegenerative diseases
Reproductive Genetics Market Analysis Report 2024-2032, Featuring Bangkok Genomics Innovation, Centogene, Fulgent Genetics, Igenomix, Invitae, PerkinElmer and Thermo Fisher Scientific
Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics
Centogene (CNTG) said Tuesday it will continue to give Takeda Pharmaceutical (TAK) access to diagnostic testing for patients with Lysosomal Storage Disorders, or LSDs, under the companies' extended ag
Centogene, Takeda Extend Diagnostic Partnership
CENTOGENE and Takeda Boost Genetic Testing for LSDs
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
Longstanding global partnership provides an efficient and timely diagnosis to patients with Lysosomal Storage Disorders (LSDs) CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 19, 2024 (GLOBE NEWSWIRE) --
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (NASDAQ:CNTG) (the "Company"), the essential life science partner for data-driven answers in rare and neurodegenerative
Centogene to Explores Strategic Alternatives, Gets Nasdaq Delisting Notice; Shares Plunge
Centogene Says It Is Exploring A Range Of Strategic Alternatives Focused On Sustainable Long-term Value Creation For The Benefit Of Its Stakeholders
The company received a staff determination letter (the "Letter") on Feb. 27, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company of the det
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ:CNTG) (the "Company"), the essential life science partner for data-driven answers in rare and neurodegenerative
CENTOGENE Explores Strategic Alternatives
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ:CNTG) (the "Company"), the essential life science partner for data-driven answers in rare and neurodegenerative
Centogene N.V.'s (NASDAQ:CNTG) Stock Retreats 27% But Revenues Haven't Escaped The Attention Of Investors
The Centogene N.V. (NASDAQ:CNTG) share price has fared very poorly over the last month, falling by a substantial 27%. The drop over the last 30 days has capped off a tough year for shareholders, wi
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (NASDAQ:CNTG) (the "Company"), the essential life science partner for data-driven answers in rare and neurodegenerative
Centogene Has Been Recognized By French Ministry Of Higher Education And Research As Qualified Organization To Support Partners Conducting R&D Projects In France. It Has Received Accreditation Under The French R&D Tax Credit Initiative For Three Years-8K
Centogene Has Been Recognized By French Ministry Of Higher Education And Research As Qualified Organization To Support Partners Conducting R&D Projects In France. It Has Received Accreditation Under T
CENTOGENE Receives French Research Tax Credit Accreditation
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (NASDAQ:CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases,
No Data